138 related articles for article (PubMed ID: 8657693)
1. [Oxidative metabolism changes in respiratory tract cells of guinea pigs during natural development of experimental tuberculosis and under specific chemotherapy].
Kaminskaia GO; Abdullaev RIu
Probl Tuberk; 1996; (2):33-6. PubMed ID: 8657693
[TBL] [Abstract][Full Text] [Related]
2. [Oxidative metabolic changes, antioxidantion, and platelet activation rat phagocytes during development of experimental specific tuberculous changes].
Kaminskaia GO; Abdullaev RIu; Gedymin LE
Probl Tuberk; 1998; (5):51-5. PubMed ID: 9866402
[TBL] [Abstract][Full Text] [Related]
3. [Features of oxidative metabolism and level of platelet activating factor in pulmonary and circulating phagocytes of tuberculosis-resistant animals at stages of experimental infection].
Kaminskaia GO; Abdullaev RIu; Gedymin LE
Probl Tuberk; 1998; (3):71-5. PubMed ID: 9691697
[TBL] [Abstract][Full Text] [Related]
4. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
5. [Changes in the fibronectin level of the blood and bronchoalveolar lavage fluid in experimental tuberculosis in guinea pigs].
Kaminskaia GO; Grigor'eva EV; Gedymin LE; Sivakov AE
Probl Tuberk; 1993; (1):50-4. PubMed ID: 8327442
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of chemotherapy of intrathoracic tuberculosis in children: late follow-up data].
Iukhimenko NV
Probl Tuberk; 2001; (5):19-22. PubMed ID: 11588952
[TBL] [Abstract][Full Text] [Related]
7. [Platelet activating factor in biological fluids of animals with different species-specific resistance at the stage of infective process after inoculation with mycobacterium tuberculosis].
Kaminskaia GO; Abdullaev RIu; Gedymin LE
Probl Tuberk; 1998; (6):58-62. PubMed ID: 10067355
[TBL] [Abstract][Full Text] [Related]
8. Management of tuberculosis.
Meissner PE; Coulter JB
N Engl J Med; 2001 Nov; 345(20):1502. PubMed ID: 11794211
[No Abstract] [Full Text] [Related]
9. [Molecular medicine and treatment of tuberculosis].
Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
[No Abstract] [Full Text] [Related]
10. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
12. Role of individual drugs in the chemotherapy of tuberculosis.
Mitchison DA
Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648
[TBL] [Abstract][Full Text] [Related]
13. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
[TBL] [Abstract][Full Text] [Related]
14. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
Iukhimenko NV
Probl Tuberk; 2000; (3):20-3. PubMed ID: 10900978
[TBL] [Abstract][Full Text] [Related]
15. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
Dekker TG; Lötter AP
Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
[No Abstract] [Full Text] [Related]
16. [Improved technology of chemotherapy of pulmonary tuberculosis complicated by other diseases].
Gavril'ev SS; Nikolaev VP; Vinokurova MK; Petukhova NIu; Gavril'eva LP; Malogulova ISh
Probl Tuberk; 2001; (2):8-11. PubMed ID: 11490482
[TBL] [Abstract][Full Text] [Related]
17. Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control.
Cohn DL
Clin Infect Dis; 2000 Jul; 31(1):120-4. PubMed ID: 10913407
[TBL] [Abstract][Full Text] [Related]
18. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
19. [The morphological reactions in the lungs during the chemotherapy of experimental tuberculosis].
Erokhin VV
Probl Tuberk; 2000; (5):15-9. PubMed ID: 11077845
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
